XIX Symposium Neuroradiologicum

Slides:



Advertisements
Similar presentations
Imaging Overview DIAS-4. Randomised, double-blind, parallel-group, placebo- controlled phase III study to evaluate the efficacy and safety of desmoteplase.
Advertisements

3/28/2017© 2009, American Heart Association. All rights reserved.
Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times Michael D. Hill.
TPA in Stroke: What's All the Fuss?. FERNE Brain Illness and Injury Course.
Some Difficult Stroke Cases: What Would You Do?
Advances in Emergency Brain Imaging Andrew W. Asimos, MD Director of Emergency Stroke Care Carolinas Medical Center Charlotte, NC.
Thrombolysis for stroke in older people.
The NINDS rt-PA Stroke Trial Prior information(Pre-Clinical, Phase I Studies, etc) Thrombolytic canalization of occluded arteries may reduce the degree.
Advanced Treatment Options for Stroke Patients Vickie Gordon PhD, ACNP-BC, CNRN.
Disclosures: Maximo C. Kiok, M.D. Medical Director of Stroke Program Trinity Health System.
Maximizing IV Thrombolytic Therapy in Acute Ischemic Stroke Kamakshi Lakshminarayan, MD PhD Assistant Professor Neurology & Epidemiology University of.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Brain Single-Photon Emission CT With HMPAO and Safety of Thrombolytic Therapy in Acute Ischemic Stroke Proceedings of the Meeting of the SPECT Safe Thrombolysis.
Ischemic Stroke Time is Brain: Or Is It?
Seeing a Stroke Developed by: K. Banasky, RN, BSN Educator GCH Emergency Services.
Neuroimaging of Ischemic Stroke With CT and MRI
Andrew W. Asimos, MD How Can We Use Advanced Neuroimaging in the ED to Optimize Treatment Options for Acute Stroke Patients?
T-PA in Treatment of Acute Stroke: What We Know From NINDS 2004 vs 2000 Sidney Starkman, MD Departments of Emergency Medicine and Neurology, UCLA UCLA.
FERNE/MEMC Session: Treating Ischemic Stroke in the 3 – 4
2015 Joint Congress on Medical Imaging and Radiation Sciences Imaging and Intervention in Acute Stroke: MR Imaging in Acute Stroke Viesha Ciura, MD, FRCPC.
Interventions in Acute Ischemic Stroke: Strategies for the New Millennium For the next 25 minutes, we will spend sometime talking about Neuroimaging.
Maximizing IV Thrombolytic Therapy in Acute Ischemic Stroke Kamakshi Lakshminarayan, MD PhD Assistant Professor Neurology & Epidemiology University of.
Original Article Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke Werner Hacke, M.D., Markku Kaste, M.D., Erich Bluhmki, Ph.D., Miroslav.
What’s on the horizon? Peter Sandercock ESC Lisbon 23rd May 2012.
Thrombolysis in acute ischaemic stroke – Updated Cochrane Thrombolysis metaanalysis JM Wardlaw, V Murray, PAG Sandercock University of Edinburgh and Karolinska.
Tissue Plasminogen Activator for Acute Ischemic Stroke National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
Evidence in the ED Byron Drumheller, MD Penn Emergency Medicine.
Overview of new acute stroke trials Shawna Cutting, MD, MS Rush University Medical Center June 9, 2015.
Intra - Arterial Thrombolysis for acute stroke
Andrew W. Asimos, MD How Can We Use Advanced Neuroimaging in the ED to Optimize Treatment Options for Acute Stroke Patients?
Acute Ischemic Stroke Treatments Patrick J. Ward, PA-S.
Mr X, 79 years old Admitted on 5/5/00 to WGH stroke unit Dense (0/5) right arm and leg paresis Aphasic CT scan excluded a bleed Given trial treatment (IST-3)
Thrombolysis for patients > 80 – a different view Peter Sandercock On behalf of the IST3 collaborative Group UKSF Glasgow 1 st December 2009.
Can patients be too mild, too severe or too old for thrombolysis? Professor Peter Sandercock University of Edinburgh ESC Hamburg 27 th May 2011 Disclosures.
Thrombolysis for acute ischaemic stroke Clinical
Spontaneous dissection of intradural vertebral and basilar arteries. Review of 55 cases regarding clinical presentation, morphology and multimodality endovascular.
Morphological and clinical results of invasive intra-arterial recanalization in the event of an acute stroke I Gubucz, Z Berentei, M Marosfői, C Óváry,
before thrombolysis in acute stroke
A multimodal step-up approach as rescue therapy of ischemic stroke L. Verganti, S. Vallone, C. Moratti, M. Malagoli, P. Carpeggiani Department of Neuroscience,
Kim, Sun-Yong, M.D. Department of Radiology Ajou University Hospital, Suwon, Korea AGGRESIVE MECHANICAL CLOT DISRUPTION FOR ACUTE ISCHEMIC STROKE WITH.
MR CLEAN Multicenter Randomized CLinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands C.B. Majoie, Y.B. Roos, A. van der.
Time Is Brain: Advanced Stroke Treatment Grahame C Gould, MD Jefferson Neurosurgical Associates at Main Line Health, Bryn Mawr Hospital Division of Neurovascular.
Sanaz Sakiani, MD Endocrinology Fellow Journal Club
Cardioembolic Stroke: Diagnosis and Management
Abstract No: eEdE-103 Submission Number: Disclosure There is no disclosure.
Dr Marc Randall Consultant Neurologist and Stroke Physician Honorary Senior Lecturer University Sheffield.
Ischemic Stroke 2010 and the Future
Treating Acute Ischemic Stroke, Can We Open Up the Time Window?
Acute Stroke Management
Thrombectomy in Acute Stroke
Acute Carotid Occlusions
Clinical Audit of Head CT in Stroke Alert Cases: Role of Radiology Resident and CT Technologist Awareness in improving Head CT reporting time K Hooda,
Acute Stroke Therapy with IV Thrombolysis Lawrence R. Wechsler, M.D.
CAS in acute stroke C. Roth‡, P. Papanagiotou‡, A. M. Politi‡, K. W. Reith‡ Department of diagnostic.
When Not to Intervene in Acute Stroke or
Baseline characteristics of the 3035 patients recruited in IST3
Icahn School of Medicine Mount Sinai Hospital
Urgent carotid intervention is safe after thrombolysis for minor to moderate acute ischemic stroke  Hernan A. Bazan, MD, FACS, Nicolas Zea, MD, Bethany.
Setareh Omran, MD Vascular Neurology Fellow
Update from education committee
Acute Ischemic Stroke First Eight Hours Dr. Mohammed Ateequr Rahman
Volume 14, Issue 5, Pages (May 2015)
Modified Rankin score 0-2
Extended Window Thrombectomy
Volume 14, Issue 5, Pages (May 2015)
Three outcome measures from the NINDS tPA trial
Jennifer E. Fugate, DO, Alejandro A. Rabinstein, MD 
An example of the predicted risk of final infarct for 2 patients with acute ischemic stroke using 2 neural networks trained, respectively, on patients.
An example of the predicted risk of final infarct for 2 patients with acute ischemic stroke using 2 neural networks trained, respectively, on patients.
Suggested imaging protocols for patients presenting with acute stroke symptoms based on the clinical scenario and the therapeutic options considered and.
Presentation transcript:

XIX Symposium Neuroradiologicum Bologna, Italy, 5. – 9. October 2010 “Time is Brain” Still a valid concept for the treatment of acute stroke patients? Rüdiger von Kummer Department of Neuroradiology Dresden University Stroke Center (DUSC) Universitätsklinikum Carl-Gustav-Carus der TU Dresden www.tu-dresden.de/medneurorad

Disclosures Chair, Steering Committee, DIAS-3/4 Steering Committee, ECASS-2, ECASS-3 Safety Committee, DIAS, DEDAS, DIAS-2, FAST CT/MRI Reading Panel: ECASS, DIAS, FAST, IST3 Outcome Adjudiction: SPORTIF, MATCH, OPAL, ONYX Fees for services, travel grants from: AB Medica, Altana, Astellas, Bayer Schering, Boehringer Ingelheim, Lundbeck, NovoNordisk, Novartis, Paion, Penumbra, Pfizer, Sanofi, Siemens Disclosures

Time is brain. Is time really brain? Be quick, but use brain, not clock!

Response to IV tPA (NINDS, Marler et al.,Neurology 2000. 55:1649)

No Treatment Beyond 3 Hours?

Treatment of Acute Ischemic Stroke Challenging the Concept of a Rigid and Universal Time Window J.C. Baron, MD; R. von Kummer, MD G.J. del Zoppo, MD Stroke 1995; 26:2219-2221

The Time-is-Brain-Concept for Acute Ischemic Stroke acknowledges the high vulnerability of brain tissue for even short periods of ischemia, has fostered special and effective service for acute stroke patients (e.g. stroke units), but widely ignores the pathophysiology of individual patients and thus excludes many patients from treatment. The Time-is-Brain-Concept for Acute Ischemic Stroke

Minimal Diagnostics in Stroke Advantages Time not required Specialist not required Special institution not required Cheap and available Disadvantage Efficiency

Guideline “Time is Brain”: Therapeutic time window and minimal diagnostics Within 3h of stroke Exclusion ICH Vessel pathology? Brain pathology?? IV thrombolysis (rt-PA)

Prejustice Early treatment with IV thrombolytics means high benefit for the patient. The efficiency of IV thrombolytics disappear over time due to the steady growth of infarction. (Time is brain). The main reason for the failure of IV thrombolytics is the disappearance of penumbra. The treatment with IV thrombolytics bears a high risk of symptomatic brain hemorrhage if initiated after 3 hours (4.5 hours).

Prejustice Early treatment with IV thrombolytics means high benefit for the patient. The efficiency of IV thrombolytics disappear over time due to the steady growth of infarction. (Time is brain). The main reason for the failure of IV thrombolytics is the disappearance of penumbra. The treatment with IV thrombolytics bears a high risk of symptomatic brain hemorrhage if initiated after 3 hours (4.5 hours).

2001 - 2007 245 : 3908 = 6%

Effectivness of IV tPA The concept „time-is-brain“ excludes the majority of patients from treatment without a diagnosis of the individual disease. The effectiveness of IV tPA was tested in a minority of acute ischemic stroke patients. The beneficial effect of IV tPA in this minority was significant in 2 RCTs only, but minor as well.

Absolute Reduction of Disability/Mortality by IV tPA in RCTs *NINDS1: retrospective

Benefit from IV Thrombolytics (Alteplase) in Randomised Controlled Studies (RCTs) Only NINDS-2 and ECASS-3 showed a significant effect Maximal effect: Absolute reduction M/M: 7% Relative reduction M/M: 9,5% (NINDS-2), 12,7% (ECASS-3) Time-window NINDS-2: 3 hours Time-window ECASS-3: 3 to 4.5 hours

Prejustice Is time really brain? Early treatment with IV thrombolytics means high benefit for the patient. The efficiency of IV thrombolytics disappear over time due to the steady growth of infarction. (Time is brain). The main reason for the failure of IV thrombolytics is the disappearance of penumbra. The treatment with IV thrombolytics bears a high risk of symptomatic brain hemorrhage if initiated after 3 hours (4.5 hours). Is time really brain?

Beneficial Outcome after IV tPA Pooled Analysis of all RCTs, N=3760 (Lees, Bluhmki, von Kummer et al. Lancet 2010;375:1695) 60 120 180 240 300 360

Potential Causes for Progressive Failure of IV tPA in RCTs Selection bias: Patients with poor prognosis were treated early Spontanous recovery: no arterial occlusion, spontaneous recanalization and tissue reperfusion Recanalisation and reperfusion not achieved Thrombolytics cannot reach the thrombus (tandem stenosis) Thrombus too big (too long) Thrombus constitution (calcified, no fibrine) Arterial obstruction not caused by thrombus, but by atheroscleosis, dissection Recanalisation without sufficient tissue reperfusion Re-Occlusion, thrombus migration Adverse events, e.g. symptomatic hemorrhage Reperfusion too late, brain already damaged to an extend that does not allow recovery

Good Clinical Outcome after Ischemic Stroke and Treatment with Placebo

Good Clinical Outcome in Trials on the Treatment with IV tPA Pooled Analysis of all RCTs, N=3760 (Lees, Bluhmki, von Kummer et al. Lancet 2010;375:1695)

Clinical deterioration (CD) In 44/374 patients (12%) Stroke 2007;38:69

51 y, m, Stroke 4 Days After Car Accident R Hemiparesis: 15:00 CT: 17:00 US: L ICA Occlusion IV rt-PA

51 y, m, Stroke 4 Days After Car Accident 1 d later after clinical deterioration

51 y, m, Stroke 4 Days After Car Accident 2 d later after clinical deterioration

Infarctpatterns after MCA Occlusion Zülch KJ Infarctpatterns after MCA Occlusion Zülch KJ. Über die Entstehung und Lokalisation der Hirninfarkte. Zbl Neurochir 1961;21: 158-178

ECASS II (N=792): Prevalence of Ischemic Edema after Stroke Onset

ECASS II (N=792): Large Ischemic Edema at Baseline % 3 11 15 14 8 1 hours after symptom onset

Infarct Core and Penumbra (CBF) in Patients with acute MCA Occlusion (Jovin et al. Stroke 2003;34:2426-2435)

Volumes of DW image (DWI) lesions (teal bars) and absolute mismatch volumes (red bars) for every patient in study Copen, W. A. et al. Radiology 2009;250:878-886 Copyright ©Radiological Society of North America, 2009

Infarctvolume and Time Minutes Hours Days Time

The ascending lenticulo-striatal arteries originate from the MCA-trunk and supply the basal ganglia. There is no collateral supply for this region.

In case of thrombo-embolic occlusion of the MCA-trunk, the basal ganglia become severely ischemic, whereas the cortical MCA territory

Prejustice Early treatment with IV thrombolytics means high benefit for the patient. The efficiency of IV thrombolytics disappear over time due to the steady growth of infarction. (Time is brain). The main reason for the failure of IV thrombolytics is the disappearance of penumbra. The treatment with IV thrombolytics bears a high risk of symptomatic brain hemorrhage if initiated after 3 hours (4.5 hours).

Major Brain Hemorrhage after IV tPA Pooled Analysis of all RCTs, N=3760 (Lees, Bluhmki, von Kummer et al. Lancet 2010;375:1695)

74 y, m, Wake-up Stroke, R Hemiparesis 25. 07. 2003, 11:15

74 y, m, Wake-up Stroke, R Hemiparesis L ICA, 25. 07. 2003, 12:00

74 y, m, Wake-up Stroke, R Hemiparesis Carotis-Wallstent: 7 mm x 50 mm, 25. 07. 2003, 12:25

74 y, m, Wake-up Stroke, R Hemiparesis 25. 07. 2003 14:15

74 y, m, Recovered from Wake-up Stroke 26. 07. 2003

The earth is not flat and the treatment of stroke can be beneficial after 3 hours

New Concept Identification of patients who should not be treated with IV tPA No arterial obstruction/perfusion deficit No thrombotic obstruction Big thrombi in ICA, M1-segment, basilar artery Extended brain damage within the affected arterial territory No time limits Appropriate choice of treatment Assessment of recanalization/reperfusion

Diagnostic Keys of Ischemic Stroke Treatment Arterial Obstruction Identification of Infarction 3 h after stroke onset

Use your Brain, but not your Clock Be quick, however